RAGE/DIAPH1 - Mechanisms and Therapeutic Opportunities in Cardiometabolic Disease

Explore the molecular mechanisms of RAGE (Receptor for Advanced Glycation End-products) and DIAPH1 (Diaphanous Related Formin 1) pathways in this 52-minute medical lecture presented by Dr. Ann Marie Schmidt from NYU Grossman School of Medicine. Learn about the intricate biological processes underlying cardiometabolic diseases and discover emerging therapeutic opportunities targeting these pathways. Examine how RAGE signaling contributes to diabetic complications, cardiovascular disease, and metabolic dysfunction, while understanding the role of DIAPH1 in cellular processes relevant to these conditions. Gain insights into current research findings and potential clinical applications from a leading expert in endocrinology and diabetes research who serves as Editor-in-Chief of Arteriosclerosis, Thrombosis, and Vascular Biology. Understand the translational implications of targeting these molecular pathways for developing novel treatments for patients with diabetes, cardiovascular disease, and related metabolic disorders.